AI summary & topic connections
Requests independent reassessment of exposure limits, realistic device testing, clear disclosures and research on chronic exposure and vulnerable groups. Calls for respectful investigation of reported electromagnetic sensitivity, environmental assessment, transparent research governance and practical exposure-reduction guidance that explains evidence and uncertainty.
- Exposure limits & oversight: “I urge HHS to independently reassess the scientific basis of current federal exposure limits.”
- Research & federal duties: “I urge HHS to fund independent, reproducible research on chronic exposure”
- Children & vulnerable groups: “Children’s developing bodies and the possibility of lifelong exposure beginning early in life warrant specific assessment.”
- Electromagnetic sensitivity: “People reporting electromagnetic sensitivity should receive respectful clinical evaluation and rigorous investigation”
- Environmental effects: “HHS should coordinate with environmental agencies to assess potential effects on wildlife, pollinators, plants, and livestock.”
- Li-Fi, fiber & alternatives: “including wired connections where feasible”
ORIGINAL COMMENT · UNEDITED TEXT
Re: Electromagnetic Fields, RF Radiation, and Wireless Radiation Exposure
Question 2 — Perspective
I am commenting as an EMF affected individual and writer who has covered wireless radiation and public-health concerns for years. This reply offers policy recommendations informed by government reports and my review of this subject, rather than original research or clinical findings.
I welcome HHS’s examination of RF/EMF exposure. The public deserves a transparent assessment of whether existing protections adequately address today’s exposure conditions, particularly for children and other potentially vulnerable populations.
Questions 5–6 and 12 — Exposure standards and health evidence
I urge HHS to independently reassess the scientific basis of current federal exposure limits. Protection against established heating effects should not substitute for evaluating potential effects from long-term exposure at lower intensities.
Please critically examine research concerning oxidative stress, DNA damage, reproductive and developmental outcomes, neurological function, and sleep. Reviews should distinguish association from causation, and experimental exposures from realistic human exposures.
Where findings conflict, HHS should explain how exposure measurement, temperature control, sample size, study design, replication, and funding sources affect its conclusions. Uncertainty should be acknowledged rather than presented as proof of safety.
Questions 8–9 and 13 — Real-world exposure and disclosure
Exposure assessment should reflect how people actually use technology: phones against the body, wearables used for extended periods, and overlapping emissions from devices and infrastructure. HHS should evaluate how duration, proximity, frequency, modulation, and simultaneous transmissions affect exposure and the interpretation of health studies.
In 2012, GAO recommended reassessing the FCC’s exposure limit and phone-testing requirements, particularly for use against the body. Its report page currently lists both recommendations as closed without implementation:
https://www.gao.gov/products/gao-12-771
HHS should work with the FCC to address these concerns and improve consumer disclosures. Any separation distances or operating conditions required for compliance should be prominent and understandable, rather than buried in technical instructions.
Question 11 — Children and potentially vulnerable populations
Children’s developing bodies and the possibility of lifelong exposure beginning early in life warrant specific assessment. HHS should explain whether existing safety margins adequately address children, pregnancy, and other potentially vulnerable groups.
Research should include long-term developmental outcomes and exposure patterns in schools and childcare settings. People reporting electromagnetic sensitivity should receive respectful clinical evaluation and rigorous investigation of their symptoms, possible contributing factors, and effective management approaches, without presuming an established cause.
Questions 14–15 — Environmental and infrastructure considerations
HHS should coordinate with environmental agencies to assess potential effects on wildlife, pollinators, plants, and livestock. Human exposure limits should not automatically be assumed to protect other species.
Infrastructure assessment should incorporate measured exposure and cumulative neighborhood conditions. Distance from an antenna alone is an incomplete measure; transmission characteristics, direction, terrain, and other sources also matter.
Questions 16–18 — Research priorities and practical action
I urge HHS to fund independent, reproducible research on chronic exposure, childhood development, reproductive health, neurological outcomes, and plausible biological mechanisms. Priorities should include longitudinal studies with better exposure measurement and replication of important findings.
Research funding and advisory processes should disclose relevant industry relationships and protect scientific independence. HHS should publish its review methods, evidence assessments, research priorities, and a timetable for public updates.
While research continues, HHS should evaluate and communicate practical, low-cost ways to reduce unnecessary exposure, including wired connections where feasible, greater distance from transmitting devices, disabling unused wireless functions, and the use of scientifically researched EMF protection devices like Blushield. Guidance should explain the evidence and remaining uncertainties.
Please use this RFI to produce meaningful research commitments, clear public guidance, and recommendations to strengthen federal protections wherever warranted. Families should be able to benefit from communications technology while receiving an honest account of what is established, what remains uncertain, and how avoidable exposure can be reduced.
Discussion
Reader replies are separate from the official HHS submission. They are reviewed before publication. Display names are not verified.